Global Metformin Hydrochloride Sustained-release Drug Supply, Demand and Key Producers, 2023-2029
The global Metformin Hydrochloride Sustained-release Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Metformin hydrochloride sustained-release drug is a medication used to treat type 2 diabetes. It is a long-acting form of metformin, which helps to lower blood sugar levels by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin.
This report studies the global Metformin Hydrochloride Sustained-release Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Metformin Hydrochloride Sustained-release Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Metformin Hydrochloride Sustained-release Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Metformin Hydrochloride Sustained-release Drug total production and demand, 2018-2029, (K Units)
Global Metformin Hydrochloride Sustained-release Drug total production value, 2018-2029, (USD Million)
Global Metformin Hydrochloride Sustained-release Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Metformin Hydrochloride Sustained-release Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Metformin Hydrochloride Sustained-release Drug domestic production, consumption, key domestic manufacturers and share
Global Metformin Hydrochloride Sustained-release Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Metformin Hydrochloride Sustained-release Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Metformin Hydrochloride Sustained-release Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Metformin Hydrochloride Sustained-release Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Viatris, Apotex, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, CSPC, Jingfeng Pharmaceutical Group and Topfond Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Metformin Hydrochloride Sustained-release Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Metformin Hydrochloride Sustained-release Drug Market, By Region:
1. How big is the global Metformin Hydrochloride Sustained-release Drug market?
2. What is the demand of the global Metformin Hydrochloride Sustained-release Drug market?
3. What is the year over year growth of the global Metformin Hydrochloride Sustained-release Drug market?
4. What is the production and production value of the global Metformin Hydrochloride Sustained-release Drug market?
5. Who are the key producers in the global Metformin Hydrochloride Sustained-release Drug market?
6. What are the growth factors driving the market demand?
Metformin hydrochloride sustained-release drug is a medication used to treat type 2 diabetes. It is a long-acting form of metformin, which helps to lower blood sugar levels by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin.
This report studies the global Metformin Hydrochloride Sustained-release Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Metformin Hydrochloride Sustained-release Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Metformin Hydrochloride Sustained-release Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Metformin Hydrochloride Sustained-release Drug total production and demand, 2018-2029, (K Units)
Global Metformin Hydrochloride Sustained-release Drug total production value, 2018-2029, (USD Million)
Global Metformin Hydrochloride Sustained-release Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Metformin Hydrochloride Sustained-release Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Metformin Hydrochloride Sustained-release Drug domestic production, consumption, key domestic manufacturers and share
Global Metformin Hydrochloride Sustained-release Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Metformin Hydrochloride Sustained-release Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Metformin Hydrochloride Sustained-release Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Metformin Hydrochloride Sustained-release Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Viatris, Apotex, Teva Pharmaceuticals, Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, CSPC, Jingfeng Pharmaceutical Group and Topfond Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Metformin Hydrochloride Sustained-release Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Metformin Hydrochloride Sustained-release Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tablet
- Capsule
- Hospital
- Clinic
- Other
- Merck
- Viatris
- Apotex
- Teva Pharmaceuticals
- Sun Pharmaceutical Industries
- Dr. Reddy's Laboratories
- CSPC
- Jingfeng Pharmaceutical Group
- Topfond Pharmaceutical
- SinocorpPharma
- CTTQ
- Shanghai Pharmaceuticals
- Tianan Pharmaceutical
- Qingdao Huanghai Pharmaceutical
- Chongqing Conquer Pharmaceutical
- Jiangsu Deyuan Pharmaceutical
- Beijing Shengyong Pharmaceutical
1. How big is the global Metformin Hydrochloride Sustained-release Drug market?
2. What is the demand of the global Metformin Hydrochloride Sustained-release Drug market?
3. What is the year over year growth of the global Metformin Hydrochloride Sustained-release Drug market?
4. What is the production and production value of the global Metformin Hydrochloride Sustained-release Drug market?
5. Who are the key producers in the global Metformin Hydrochloride Sustained-release Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Metformin Hydrochloride Sustained-release Drug Introduction
1.2 World Metformin Hydrochloride Sustained-release Drug Supply & Forecast
1.2.1 World Metformin Hydrochloride Sustained-release Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.2.3 World Metformin Hydrochloride Sustained-release Drug Pricing Trends (2018-2029)
1.3 World Metformin Hydrochloride Sustained-release Drug Production by Region (Based on Production Site)
1.3.1 World Metformin Hydrochloride Sustained-release Drug Production Value by Region (2018-2029)
1.3.2 World Metformin Hydrochloride Sustained-release Drug Production by Region (2018-2029)
1.3.3 World Metformin Hydrochloride Sustained-release Drug Average Price by Region (2018-2029)
1.3.4 North America Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.3.5 Europe Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.3.6 China Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.3.7 Japan Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Metformin Hydrochloride Sustained-release Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Metformin Hydrochloride Sustained-release Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Metformin Hydrochloride Sustained-release Drug Demand (2018-2029)
2.2 World Metformin Hydrochloride Sustained-release Drug Consumption by Region
2.2.1 World Metformin Hydrochloride Sustained-release Drug Consumption by Region (2018-2023)
2.2.2 World Metformin Hydrochloride Sustained-release Drug Consumption Forecast by Region (2024-2029)
2.3 United States Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.4 China Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.5 Europe Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.6 Japan Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.7 South Korea Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.8 ASEAN Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.9 India Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
3 WORLD METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Metformin Hydrochloride Sustained-release Drug Production Value by Manufacturer (2018-2023)
3.2 World Metformin Hydrochloride Sustained-release Drug Production by Manufacturer (2018-2023)
3.3 World Metformin Hydrochloride Sustained-release Drug Average Price by Manufacturer (2018-2023)
3.4 Metformin Hydrochloride Sustained-release Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Metformin Hydrochloride Sustained-release Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Metformin Hydrochloride Sustained-release Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Metformin Hydrochloride Sustained-release Drug in 2022
3.6 Metformin Hydrochloride Sustained-release Drug Market: Overall Company Footprint Analysis
3.6.1 Metformin Hydrochloride Sustained-release Drug Market: Region Footprint
3.6.2 Metformin Hydrochloride Sustained-release Drug Market: Company Product Type Footprint
3.6.3 Metformin Hydrochloride Sustained-release Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Value Comparison
4.1.1 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Comparison
4.2.1 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Metformin Hydrochloride Sustained-release Drug Consumption Comparison
4.3.1 United States VS China: Metformin Hydrochloride Sustained-release Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Metformin Hydrochloride Sustained-release Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Metformin Hydrochloride Sustained-release Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023)
4.5 China Based Metformin Hydrochloride Sustained-release Drug Manufacturers and Market Share
4.5.1 China Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023)
4.6 Rest of World Based Metformin Hydrochloride Sustained-release Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Metformin Hydrochloride Sustained-release Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tablet
5.2.2 Capsule
5.3 Market Segment by Type
5.3.1 World Metformin Hydrochloride Sustained-release Drug Production by Type (2018-2029)
5.3.2 World Metformin Hydrochloride Sustained-release Drug Production Value by Type (2018-2029)
5.3.3 World Metformin Hydrochloride Sustained-release Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Metformin Hydrochloride Sustained-release Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Metformin Hydrochloride Sustained-release Drug Production by Application (2018-2029)
6.3.2 World Metformin Hydrochloride Sustained-release Drug Production Value by Application (2018-2029)
6.3.3 World Metformin Hydrochloride Sustained-release Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Metformin Hydrochloride Sustained-release Drug Product and Services
7.1.4 Merck Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Viatris
7.2.1 Viatris Details
7.2.2 Viatris Major Business
7.2.3 Viatris Metformin Hydrochloride Sustained-release Drug Product and Services
7.2.4 Viatris Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Viatris Recent Developments/Updates
7.2.6 Viatris Competitive Strengths & Weaknesses
7.3 Apotex
7.3.1 Apotex Details
7.3.2 Apotex Major Business
7.3.3 Apotex Metformin Hydrochloride Sustained-release Drug Product and Services
7.3.4 Apotex Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Apotex Recent Developments/Updates
7.3.6 Apotex Competitive Strengths & Weaknesses
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Details
7.4.2 Teva Pharmaceuticals Major Business
7.4.3 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product and Services
7.4.4 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Pharmaceuticals Recent Developments/Updates
7.4.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Sun Pharmaceutical Industries
7.5.1 Sun Pharmaceutical Industries Details
7.5.2 Sun Pharmaceutical Industries Major Business
7.5.3 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product and Services
7.5.4 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.5.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
7.6 Dr. Reddy's Laboratories
7.6.1 Dr. Reddy's Laboratories Details
7.6.2 Dr. Reddy's Laboratories Major Business
7.6.3 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product and Services
7.6.4 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.6.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
7.7 CSPC
7.7.1 CSPC Details
7.7.2 CSPC Major Business
7.7.3 CSPC Metformin Hydrochloride Sustained-release Drug Product and Services
7.7.4 CSPC Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 CSPC Recent Developments/Updates
7.7.6 CSPC Competitive Strengths & Weaknesses
7.8 Jingfeng Pharmaceutical Group
7.8.1 Jingfeng Pharmaceutical Group Details
7.8.2 Jingfeng Pharmaceutical Group Major Business
7.8.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product and Services
7.8.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Jingfeng Pharmaceutical Group Recent Developments/Updates
7.8.6 Jingfeng Pharmaceutical Group Competitive Strengths & Weaknesses
7.9 Topfond Pharmaceutical
7.9.1 Topfond Pharmaceutical Details
7.9.2 Topfond Pharmaceutical Major Business
7.9.3 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.9.4 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Topfond Pharmaceutical Recent Developments/Updates
7.9.6 Topfond Pharmaceutical Competitive Strengths & Weaknesses
7.10 SinocorpPharma
7.10.1 SinocorpPharma Details
7.10.2 SinocorpPharma Major Business
7.10.3 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product and Services
7.10.4 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 SinocorpPharma Recent Developments/Updates
7.10.6 SinocorpPharma Competitive Strengths & Weaknesses
7.11 CTTQ
7.11.1 CTTQ Details
7.11.2 CTTQ Major Business
7.11.3 CTTQ Metformin Hydrochloride Sustained-release Drug Product and Services
7.11.4 CTTQ Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 CTTQ Recent Developments/Updates
7.11.6 CTTQ Competitive Strengths & Weaknesses
7.12 Shanghai Pharmaceuticals
7.12.1 Shanghai Pharmaceuticals Details
7.12.2 Shanghai Pharmaceuticals Major Business
7.12.3 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product and Services
7.12.4 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Shanghai Pharmaceuticals Recent Developments/Updates
7.12.6 Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Tianan Pharmaceutical
7.13.1 Tianan Pharmaceutical Details
7.13.2 Tianan Pharmaceutical Major Business
7.13.3 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.13.4 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Tianan Pharmaceutical Recent Developments/Updates
7.13.6 Tianan Pharmaceutical Competitive Strengths & Weaknesses
7.14 Qingdao Huanghai Pharmaceutical
7.14.1 Qingdao Huanghai Pharmaceutical Details
7.14.2 Qingdao Huanghai Pharmaceutical Major Business
7.14.3 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.14.4 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Qingdao Huanghai Pharmaceutical Recent Developments/Updates
7.14.6 Qingdao Huanghai Pharmaceutical Competitive Strengths & Weaknesses
7.15 Chongqing Conquer Pharmaceutical
7.15.1 Chongqing Conquer Pharmaceutical Details
7.15.2 Chongqing Conquer Pharmaceutical Major Business
7.15.3 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.15.4 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Chongqing Conquer Pharmaceutical Recent Developments/Updates
7.15.6 Chongqing Conquer Pharmaceutical Competitive Strengths & Weaknesses
7.16 Jiangsu Deyuan Pharmaceutical
7.16.1 Jiangsu Deyuan Pharmaceutical Details
7.16.2 Jiangsu Deyuan Pharmaceutical Major Business
7.16.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.16.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
7.16.6 Jiangsu Deyuan Pharmaceutical Competitive Strengths & Weaknesses
7.17 Beijing Shengyong Pharmaceutical
7.17.1 Beijing Shengyong Pharmaceutical Details
7.17.2 Beijing Shengyong Pharmaceutical Major Business
7.17.3 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.17.4 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Beijing Shengyong Pharmaceutical Recent Developments/Updates
7.17.6 Beijing Shengyong Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Metformin Hydrochloride Sustained-release Drug Industry Chain
8.2 Metformin Hydrochloride Sustained-release Drug Upstream Analysis
8.2.1 Metformin Hydrochloride Sustained-release Drug Core Raw Materials
8.2.2 Main Manufacturers of Metformin Hydrochloride Sustained-release Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Metformin Hydrochloride Sustained-release Drug Production Mode
8.6 Metformin Hydrochloride Sustained-release Drug Procurement Model
8.7 Metformin Hydrochloride Sustained-release Drug Industry Sales Model and Sales Channels
8.7.1 Metformin Hydrochloride Sustained-release Drug Sales Model
8.7.2 Metformin Hydrochloride Sustained-release Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Metformin Hydrochloride Sustained-release Drug Introduction
1.2 World Metformin Hydrochloride Sustained-release Drug Supply & Forecast
1.2.1 World Metformin Hydrochloride Sustained-release Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.2.3 World Metformin Hydrochloride Sustained-release Drug Pricing Trends (2018-2029)
1.3 World Metformin Hydrochloride Sustained-release Drug Production by Region (Based on Production Site)
1.3.1 World Metformin Hydrochloride Sustained-release Drug Production Value by Region (2018-2029)
1.3.2 World Metformin Hydrochloride Sustained-release Drug Production by Region (2018-2029)
1.3.3 World Metformin Hydrochloride Sustained-release Drug Average Price by Region (2018-2029)
1.3.4 North America Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.3.5 Europe Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.3.6 China Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.3.7 Japan Metformin Hydrochloride Sustained-release Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Metformin Hydrochloride Sustained-release Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Metformin Hydrochloride Sustained-release Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Metformin Hydrochloride Sustained-release Drug Demand (2018-2029)
2.2 World Metformin Hydrochloride Sustained-release Drug Consumption by Region
2.2.1 World Metformin Hydrochloride Sustained-release Drug Consumption by Region (2018-2023)
2.2.2 World Metformin Hydrochloride Sustained-release Drug Consumption Forecast by Region (2024-2029)
2.3 United States Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.4 China Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.5 Europe Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.6 Japan Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.7 South Korea Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.8 ASEAN Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
2.9 India Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029)
3 WORLD METFORMIN HYDROCHLORIDE SUSTAINED-RELEASE DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Metformin Hydrochloride Sustained-release Drug Production Value by Manufacturer (2018-2023)
3.2 World Metformin Hydrochloride Sustained-release Drug Production by Manufacturer (2018-2023)
3.3 World Metformin Hydrochloride Sustained-release Drug Average Price by Manufacturer (2018-2023)
3.4 Metformin Hydrochloride Sustained-release Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Metformin Hydrochloride Sustained-release Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Metformin Hydrochloride Sustained-release Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Metformin Hydrochloride Sustained-release Drug in 2022
3.6 Metformin Hydrochloride Sustained-release Drug Market: Overall Company Footprint Analysis
3.6.1 Metformin Hydrochloride Sustained-release Drug Market: Region Footprint
3.6.2 Metformin Hydrochloride Sustained-release Drug Market: Company Product Type Footprint
3.6.3 Metformin Hydrochloride Sustained-release Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Value Comparison
4.1.1 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Comparison
4.2.1 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Metformin Hydrochloride Sustained-release Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Metformin Hydrochloride Sustained-release Drug Consumption Comparison
4.3.1 United States VS China: Metformin Hydrochloride Sustained-release Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Metformin Hydrochloride Sustained-release Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Metformin Hydrochloride Sustained-release Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023)
4.5 China Based Metformin Hydrochloride Sustained-release Drug Manufacturers and Market Share
4.5.1 China Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023)
4.6 Rest of World Based Metformin Hydrochloride Sustained-release Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Metformin Hydrochloride Sustained-release Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tablet
5.2.2 Capsule
5.3 Market Segment by Type
5.3.1 World Metformin Hydrochloride Sustained-release Drug Production by Type (2018-2029)
5.3.2 World Metformin Hydrochloride Sustained-release Drug Production Value by Type (2018-2029)
5.3.3 World Metformin Hydrochloride Sustained-release Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Metformin Hydrochloride Sustained-release Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Metformin Hydrochloride Sustained-release Drug Production by Application (2018-2029)
6.3.2 World Metformin Hydrochloride Sustained-release Drug Production Value by Application (2018-2029)
6.3.3 World Metformin Hydrochloride Sustained-release Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Metformin Hydrochloride Sustained-release Drug Product and Services
7.1.4 Merck Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Viatris
7.2.1 Viatris Details
7.2.2 Viatris Major Business
7.2.3 Viatris Metformin Hydrochloride Sustained-release Drug Product and Services
7.2.4 Viatris Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Viatris Recent Developments/Updates
7.2.6 Viatris Competitive Strengths & Weaknesses
7.3 Apotex
7.3.1 Apotex Details
7.3.2 Apotex Major Business
7.3.3 Apotex Metformin Hydrochloride Sustained-release Drug Product and Services
7.3.4 Apotex Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Apotex Recent Developments/Updates
7.3.6 Apotex Competitive Strengths & Weaknesses
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Details
7.4.2 Teva Pharmaceuticals Major Business
7.4.3 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product and Services
7.4.4 Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Pharmaceuticals Recent Developments/Updates
7.4.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Sun Pharmaceutical Industries
7.5.1 Sun Pharmaceutical Industries Details
7.5.2 Sun Pharmaceutical Industries Major Business
7.5.3 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product and Services
7.5.4 Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.5.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
7.6 Dr. Reddy's Laboratories
7.6.1 Dr. Reddy's Laboratories Details
7.6.2 Dr. Reddy's Laboratories Major Business
7.6.3 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product and Services
7.6.4 Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.6.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
7.7 CSPC
7.7.1 CSPC Details
7.7.2 CSPC Major Business
7.7.3 CSPC Metformin Hydrochloride Sustained-release Drug Product and Services
7.7.4 CSPC Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 CSPC Recent Developments/Updates
7.7.6 CSPC Competitive Strengths & Weaknesses
7.8 Jingfeng Pharmaceutical Group
7.8.1 Jingfeng Pharmaceutical Group Details
7.8.2 Jingfeng Pharmaceutical Group Major Business
7.8.3 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product and Services
7.8.4 Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Jingfeng Pharmaceutical Group Recent Developments/Updates
7.8.6 Jingfeng Pharmaceutical Group Competitive Strengths & Weaknesses
7.9 Topfond Pharmaceutical
7.9.1 Topfond Pharmaceutical Details
7.9.2 Topfond Pharmaceutical Major Business
7.9.3 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.9.4 Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Topfond Pharmaceutical Recent Developments/Updates
7.9.6 Topfond Pharmaceutical Competitive Strengths & Weaknesses
7.10 SinocorpPharma
7.10.1 SinocorpPharma Details
7.10.2 SinocorpPharma Major Business
7.10.3 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product and Services
7.10.4 SinocorpPharma Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 SinocorpPharma Recent Developments/Updates
7.10.6 SinocorpPharma Competitive Strengths & Weaknesses
7.11 CTTQ
7.11.1 CTTQ Details
7.11.2 CTTQ Major Business
7.11.3 CTTQ Metformin Hydrochloride Sustained-release Drug Product and Services
7.11.4 CTTQ Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 CTTQ Recent Developments/Updates
7.11.6 CTTQ Competitive Strengths & Weaknesses
7.12 Shanghai Pharmaceuticals
7.12.1 Shanghai Pharmaceuticals Details
7.12.2 Shanghai Pharmaceuticals Major Business
7.12.3 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product and Services
7.12.4 Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Shanghai Pharmaceuticals Recent Developments/Updates
7.12.6 Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Tianan Pharmaceutical
7.13.1 Tianan Pharmaceutical Details
7.13.2 Tianan Pharmaceutical Major Business
7.13.3 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.13.4 Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Tianan Pharmaceutical Recent Developments/Updates
7.13.6 Tianan Pharmaceutical Competitive Strengths & Weaknesses
7.14 Qingdao Huanghai Pharmaceutical
7.14.1 Qingdao Huanghai Pharmaceutical Details
7.14.2 Qingdao Huanghai Pharmaceutical Major Business
7.14.3 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.14.4 Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Qingdao Huanghai Pharmaceutical Recent Developments/Updates
7.14.6 Qingdao Huanghai Pharmaceutical Competitive Strengths & Weaknesses
7.15 Chongqing Conquer Pharmaceutical
7.15.1 Chongqing Conquer Pharmaceutical Details
7.15.2 Chongqing Conquer Pharmaceutical Major Business
7.15.3 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.15.4 Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Chongqing Conquer Pharmaceutical Recent Developments/Updates
7.15.6 Chongqing Conquer Pharmaceutical Competitive Strengths & Weaknesses
7.16 Jiangsu Deyuan Pharmaceutical
7.16.1 Jiangsu Deyuan Pharmaceutical Details
7.16.2 Jiangsu Deyuan Pharmaceutical Major Business
7.16.3 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.16.4 Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
7.16.6 Jiangsu Deyuan Pharmaceutical Competitive Strengths & Weaknesses
7.17 Beijing Shengyong Pharmaceutical
7.17.1 Beijing Shengyong Pharmaceutical Details
7.17.2 Beijing Shengyong Pharmaceutical Major Business
7.17.3 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
7.17.4 Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Beijing Shengyong Pharmaceutical Recent Developments/Updates
7.17.6 Beijing Shengyong Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Metformin Hydrochloride Sustained-release Drug Industry Chain
8.2 Metformin Hydrochloride Sustained-release Drug Upstream Analysis
8.2.1 Metformin Hydrochloride Sustained-release Drug Core Raw Materials
8.2.2 Main Manufacturers of Metformin Hydrochloride Sustained-release Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Metformin Hydrochloride Sustained-release Drug Production Mode
8.6 Metformin Hydrochloride Sustained-release Drug Procurement Model
8.7 Metformin Hydrochloride Sustained-release Drug Industry Sales Model and Sales Channels
8.7.1 Metformin Hydrochloride Sustained-release Drug Sales Model
8.7.2 Metformin Hydrochloride Sustained-release Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Metformin Hydrochloride Sustained-release Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Metformin Hydrochloride Sustained-release Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Metformin Hydrochloride Sustained-release Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Region (2018-2023)
Table 5. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Region (2024-2029)
Table 6. World Metformin Hydrochloride Sustained-release Drug Production by Region (2018-2023) & (K Units)
Table 7. World Metformin Hydrochloride Sustained-release Drug Production by Region (2024-2029) & (K Units)
Table 8. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Region (2018-2023)
Table 9. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Region (2024-2029)
Table 10. World Metformin Hydrochloride Sustained-release Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Metformin Hydrochloride Sustained-release Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Metformin Hydrochloride Sustained-release Drug Major Market Trends
Table 13. World Metformin Hydrochloride Sustained-release Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Metformin Hydrochloride Sustained-release Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Metformin Hydrochloride Sustained-release Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Metformin Hydrochloride Sustained-release Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Metformin Hydrochloride Sustained-release Drug Producers in 2022
Table 18. World Metformin Hydrochloride Sustained-release Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Metformin Hydrochloride Sustained-release Drug Producers in 2022
Table 20. World Metformin Hydrochloride Sustained-release Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Metformin Hydrochloride Sustained-release Drug Company Evaluation Quadrant
Table 22. World Metformin Hydrochloride Sustained-release Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Metformin Hydrochloride Sustained-release Drug Production Site of Key Manufacturer
Table 24. Metformin Hydrochloride Sustained-release Drug Market: Company Product Type Footprint
Table 25. Metformin Hydrochloride Sustained-release Drug Market: Company Product Application Footprint
Table 26. Metformin Hydrochloride Sustained-release Drug Competitive Factors
Table 27. Metformin Hydrochloride Sustained-release Drug New Entrant and Capacity Expansion Plans
Table 28. Metformin Hydrochloride Sustained-release Drug Mergers & Acquisitions Activity
Table 29. United States VS China Metformin Hydrochloride Sustained-release Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Metformin Hydrochloride Sustained-release Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Metformin Hydrochloride Sustained-release Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share (2018-2023)
Table 37. China Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share (2018-2023)
Table 47. World Metformin Hydrochloride Sustained-release Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Metformin Hydrochloride Sustained-release Drug Production by Type (2018-2023) & (K Units)
Table 49. World Metformin Hydrochloride Sustained-release Drug Production by Type (2024-2029) & (K Units)
Table 50. World Metformin Hydrochloride Sustained-release Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Metformin Hydrochloride Sustained-release Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Metformin Hydrochloride Sustained-release Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Metformin Hydrochloride Sustained-release Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Metformin Hydrochloride Sustained-release Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Metformin Hydrochloride Sustained-release Drug Production by Application (2018-2023) & (K Units)
Table 56. World Metformin Hydrochloride Sustained-release Drug Production by Application (2024-2029) & (K Units)
Table 57. World Metformin Hydrochloride Sustained-release Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Metformin Hydrochloride Sustained-release Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Metformin Hydrochloride Sustained-release Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Metformin Hydrochloride Sustained-release Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Metformin Hydrochloride Sustained-release Drug Product and Services
Table 64. Merck Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Viatris Basic Information, Manufacturing Base and Competitors
Table 68. Viatris Major Business
Table 69. Viatris Metformin Hydrochloride Sustained-release Drug Product and Services
Table 70. Viatris Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Viatris Recent Developments/Updates
Table 72. Viatris Competitive Strengths & Weaknesses
Table 73. Apotex Basic Information, Manufacturing Base and Competitors
Table 74. Apotex Major Business
Table 75. Apotex Metformin Hydrochloride Sustained-release Drug Product and Services
Table 76. Apotex Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Apotex Recent Developments/Updates
Table 78. Apotex Competitive Strengths & Weaknesses
Table 79. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Teva Pharmaceuticals Major Business
Table 81. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product and Services
Table 82. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Pharmaceuticals Recent Developments/Updates
Table 84. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 86. Sun Pharmaceutical Industries Major Business
Table 87. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product and Services
Table 88. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sun Pharmaceutical Industries Recent Developments/Updates
Table 90. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 91. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 92. Dr. Reddy's Laboratories Major Business
Table 93. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product and Services
Table 94. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Dr. Reddy's Laboratories Recent Developments/Updates
Table 96. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 97. CSPC Basic Information, Manufacturing Base and Competitors
Table 98. CSPC Major Business
Table 99. CSPC Metformin Hydrochloride Sustained-release Drug Product and Services
Table 100. CSPC Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. CSPC Recent Developments/Updates
Table 102. CSPC Competitive Strengths & Weaknesses
Table 103. Jingfeng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 104. Jingfeng Pharmaceutical Group Major Business
Table 105. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product and Services
Table 106. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Jingfeng Pharmaceutical Group Recent Developments/Updates
Table 108. Jingfeng Pharmaceutical Group Competitive Strengths & Weaknesses
Table 109. Topfond Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Topfond Pharmaceutical Major Business
Table 111. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 112. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Topfond Pharmaceutical Recent Developments/Updates
Table 114. Topfond Pharmaceutical Competitive Strengths & Weaknesses
Table 115. SinocorpPharma Basic Information, Manufacturing Base and Competitors
Table 116. SinocorpPharma Major Business
Table 117. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product and Services
Table 118. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. SinocorpPharma Recent Developments/Updates
Table 120. SinocorpPharma Competitive Strengths & Weaknesses
Table 121. CTTQ Basic Information, Manufacturing Base and Competitors
Table 122. CTTQ Major Business
Table 123. CTTQ Metformin Hydrochloride Sustained-release Drug Product and Services
Table 124. CTTQ Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. CTTQ Recent Developments/Updates
Table 126. CTTQ Competitive Strengths & Weaknesses
Table 127. Shanghai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Shanghai Pharmaceuticals Major Business
Table 129. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product and Services
Table 130. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Shanghai Pharmaceuticals Recent Developments/Updates
Table 132. Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. Tianan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Tianan Pharmaceutical Major Business
Table 135. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 136. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Tianan Pharmaceutical Recent Developments/Updates
Table 138. Tianan Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Qingdao Huanghai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Qingdao Huanghai Pharmaceutical Major Business
Table 141. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 142. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Qingdao Huanghai Pharmaceutical Recent Developments/Updates
Table 144. Qingdao Huanghai Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Chongqing Conquer Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Chongqing Conquer Pharmaceutical Major Business
Table 147. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 148. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Chongqing Conquer Pharmaceutical Recent Developments/Updates
Table 150. Chongqing Conquer Pharmaceutical Competitive Strengths & Weaknesses
Table 151. Jiangsu Deyuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Jiangsu Deyuan Pharmaceutical Major Business
Table 153. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 154. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 156. Beijing Shengyong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 157. Beijing Shengyong Pharmaceutical Major Business
Table 158. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 159. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Metformin Hydrochloride Sustained-release Drug Upstream (Raw Materials)
Table 161. Metformin Hydrochloride Sustained-release Drug Typical Customers
Table 162. Metformin Hydrochloride Sustained-release Drug Typical Distributors
Table 1. World Metformin Hydrochloride Sustained-release Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Metformin Hydrochloride Sustained-release Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Metformin Hydrochloride Sustained-release Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Region (2018-2023)
Table 5. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Region (2024-2029)
Table 6. World Metformin Hydrochloride Sustained-release Drug Production by Region (2018-2023) & (K Units)
Table 7. World Metformin Hydrochloride Sustained-release Drug Production by Region (2024-2029) & (K Units)
Table 8. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Region (2018-2023)
Table 9. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Region (2024-2029)
Table 10. World Metformin Hydrochloride Sustained-release Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Metformin Hydrochloride Sustained-release Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Metformin Hydrochloride Sustained-release Drug Major Market Trends
Table 13. World Metformin Hydrochloride Sustained-release Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Metformin Hydrochloride Sustained-release Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Metformin Hydrochloride Sustained-release Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Metformin Hydrochloride Sustained-release Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Metformin Hydrochloride Sustained-release Drug Producers in 2022
Table 18. World Metformin Hydrochloride Sustained-release Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Metformin Hydrochloride Sustained-release Drug Producers in 2022
Table 20. World Metformin Hydrochloride Sustained-release Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Metformin Hydrochloride Sustained-release Drug Company Evaluation Quadrant
Table 22. World Metformin Hydrochloride Sustained-release Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Metformin Hydrochloride Sustained-release Drug Production Site of Key Manufacturer
Table 24. Metformin Hydrochloride Sustained-release Drug Market: Company Product Type Footprint
Table 25. Metformin Hydrochloride Sustained-release Drug Market: Company Product Application Footprint
Table 26. Metformin Hydrochloride Sustained-release Drug Competitive Factors
Table 27. Metformin Hydrochloride Sustained-release Drug New Entrant and Capacity Expansion Plans
Table 28. Metformin Hydrochloride Sustained-release Drug Mergers & Acquisitions Activity
Table 29. United States VS China Metformin Hydrochloride Sustained-release Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Metformin Hydrochloride Sustained-release Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Metformin Hydrochloride Sustained-release Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share (2018-2023)
Table 37. China Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Metformin Hydrochloride Sustained-release Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share (2018-2023)
Table 47. World Metformin Hydrochloride Sustained-release Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Metformin Hydrochloride Sustained-release Drug Production by Type (2018-2023) & (K Units)
Table 49. World Metformin Hydrochloride Sustained-release Drug Production by Type (2024-2029) & (K Units)
Table 50. World Metformin Hydrochloride Sustained-release Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Metformin Hydrochloride Sustained-release Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Metformin Hydrochloride Sustained-release Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Metformin Hydrochloride Sustained-release Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Metformin Hydrochloride Sustained-release Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Metformin Hydrochloride Sustained-release Drug Production by Application (2018-2023) & (K Units)
Table 56. World Metformin Hydrochloride Sustained-release Drug Production by Application (2024-2029) & (K Units)
Table 57. World Metformin Hydrochloride Sustained-release Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Metformin Hydrochloride Sustained-release Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Metformin Hydrochloride Sustained-release Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Metformin Hydrochloride Sustained-release Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Metformin Hydrochloride Sustained-release Drug Product and Services
Table 64. Merck Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Viatris Basic Information, Manufacturing Base and Competitors
Table 68. Viatris Major Business
Table 69. Viatris Metformin Hydrochloride Sustained-release Drug Product and Services
Table 70. Viatris Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Viatris Recent Developments/Updates
Table 72. Viatris Competitive Strengths & Weaknesses
Table 73. Apotex Basic Information, Manufacturing Base and Competitors
Table 74. Apotex Major Business
Table 75. Apotex Metformin Hydrochloride Sustained-release Drug Product and Services
Table 76. Apotex Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Apotex Recent Developments/Updates
Table 78. Apotex Competitive Strengths & Weaknesses
Table 79. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Teva Pharmaceuticals Major Business
Table 81. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product and Services
Table 82. Teva Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Pharmaceuticals Recent Developments/Updates
Table 84. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 85. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 86. Sun Pharmaceutical Industries Major Business
Table 87. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Product and Services
Table 88. Sun Pharmaceutical Industries Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sun Pharmaceutical Industries Recent Developments/Updates
Table 90. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 91. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 92. Dr. Reddy's Laboratories Major Business
Table 93. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Product and Services
Table 94. Dr. Reddy's Laboratories Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Dr. Reddy's Laboratories Recent Developments/Updates
Table 96. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
Table 97. CSPC Basic Information, Manufacturing Base and Competitors
Table 98. CSPC Major Business
Table 99. CSPC Metformin Hydrochloride Sustained-release Drug Product and Services
Table 100. CSPC Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. CSPC Recent Developments/Updates
Table 102. CSPC Competitive Strengths & Weaknesses
Table 103. Jingfeng Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 104. Jingfeng Pharmaceutical Group Major Business
Table 105. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Product and Services
Table 106. Jingfeng Pharmaceutical Group Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Jingfeng Pharmaceutical Group Recent Developments/Updates
Table 108. Jingfeng Pharmaceutical Group Competitive Strengths & Weaknesses
Table 109. Topfond Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Topfond Pharmaceutical Major Business
Table 111. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 112. Topfond Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Topfond Pharmaceutical Recent Developments/Updates
Table 114. Topfond Pharmaceutical Competitive Strengths & Weaknesses
Table 115. SinocorpPharma Basic Information, Manufacturing Base and Competitors
Table 116. SinocorpPharma Major Business
Table 117. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Product and Services
Table 118. SinocorpPharma Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. SinocorpPharma Recent Developments/Updates
Table 120. SinocorpPharma Competitive Strengths & Weaknesses
Table 121. CTTQ Basic Information, Manufacturing Base and Competitors
Table 122. CTTQ Major Business
Table 123. CTTQ Metformin Hydrochloride Sustained-release Drug Product and Services
Table 124. CTTQ Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. CTTQ Recent Developments/Updates
Table 126. CTTQ Competitive Strengths & Weaknesses
Table 127. Shanghai Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Shanghai Pharmaceuticals Major Business
Table 129. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Product and Services
Table 130. Shanghai Pharmaceuticals Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Shanghai Pharmaceuticals Recent Developments/Updates
Table 132. Shanghai Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. Tianan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Tianan Pharmaceutical Major Business
Table 135. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 136. Tianan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Tianan Pharmaceutical Recent Developments/Updates
Table 138. Tianan Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Qingdao Huanghai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Qingdao Huanghai Pharmaceutical Major Business
Table 141. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 142. Qingdao Huanghai Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Qingdao Huanghai Pharmaceutical Recent Developments/Updates
Table 144. Qingdao Huanghai Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Chongqing Conquer Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Chongqing Conquer Pharmaceutical Major Business
Table 147. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 148. Chongqing Conquer Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Chongqing Conquer Pharmaceutical Recent Developments/Updates
Table 150. Chongqing Conquer Pharmaceutical Competitive Strengths & Weaknesses
Table 151. Jiangsu Deyuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Jiangsu Deyuan Pharmaceutical Major Business
Table 153. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 154. Jiangsu Deyuan Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Jiangsu Deyuan Pharmaceutical Recent Developments/Updates
Table 156. Beijing Shengyong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 157. Beijing Shengyong Pharmaceutical Major Business
Table 158. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Product and Services
Table 159. Beijing Shengyong Pharmaceutical Metformin Hydrochloride Sustained-release Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Metformin Hydrochloride Sustained-release Drug Upstream (Raw Materials)
Table 161. Metformin Hydrochloride Sustained-release Drug Typical Customers
Table 162. Metformin Hydrochloride Sustained-release Drug Typical Distributors
LIST OF FIGURES
Figure 1. Metformin Hydrochloride Sustained-release Drug Picture
Figure 2. World Metformin Hydrochloride Sustained-release Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Metformin Hydrochloride Sustained-release Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 5. World Metformin Hydrochloride Sustained-release Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Region (2018-2029)
Figure 8. North America Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 9. Europe Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 10. China Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 11. Japan Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 12. Metformin Hydrochloride Sustained-release Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 15. World Metformin Hydrochloride Sustained-release Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 17. China Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 22. India Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Metformin Hydrochloride Sustained-release Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Metformin Hydrochloride Sustained-release Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Metformin Hydrochloride Sustained-release Drug Markets in 2022
Figure 26. United States VS China: Metformin Hydrochloride Sustained-release Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Metformin Hydrochloride Sustained-release Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Metformin Hydrochloride Sustained-release Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share 2022
Figure 30. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share 2022
Figure 32. World Metformin Hydrochloride Sustained-release Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Type in 2022
Figure 34. Tablet
Figure 35. Capsule
Figure 36. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Type (2018-2029)
Figure 37. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Metformin Hydrochloride Sustained-release Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Metformin Hydrochloride Sustained-release Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Application (2018-2029)
Figure 45. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Metformin Hydrochloride Sustained-release Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Metformin Hydrochloride Sustained-release Drug Industry Chain
Figure 48. Metformin Hydrochloride Sustained-release Drug Procurement Model
Figure 49. Metformin Hydrochloride Sustained-release Drug Sales Model
Figure 50. Metformin Hydrochloride Sustained-release Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Metformin Hydrochloride Sustained-release Drug Picture
Figure 2. World Metformin Hydrochloride Sustained-release Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Metformin Hydrochloride Sustained-release Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 5. World Metformin Hydrochloride Sustained-release Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Region (2018-2029)
Figure 8. North America Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 9. Europe Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 10. China Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 11. Japan Metformin Hydrochloride Sustained-release Drug Production (2018-2029) & (K Units)
Figure 12. Metformin Hydrochloride Sustained-release Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 15. World Metformin Hydrochloride Sustained-release Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 17. China Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 22. India Metformin Hydrochloride Sustained-release Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Metformin Hydrochloride Sustained-release Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Metformin Hydrochloride Sustained-release Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Metformin Hydrochloride Sustained-release Drug Markets in 2022
Figure 26. United States VS China: Metformin Hydrochloride Sustained-release Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Metformin Hydrochloride Sustained-release Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Metformin Hydrochloride Sustained-release Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share 2022
Figure 30. China Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Metformin Hydrochloride Sustained-release Drug Production Market Share 2022
Figure 32. World Metformin Hydrochloride Sustained-release Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Type in 2022
Figure 34. Tablet
Figure 35. Capsule
Figure 36. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Type (2018-2029)
Figure 37. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Metformin Hydrochloride Sustained-release Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Metformin Hydrochloride Sustained-release Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Metformin Hydrochloride Sustained-release Drug Production Market Share by Application (2018-2029)
Figure 45. World Metformin Hydrochloride Sustained-release Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Metformin Hydrochloride Sustained-release Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Metformin Hydrochloride Sustained-release Drug Industry Chain
Figure 48. Metformin Hydrochloride Sustained-release Drug Procurement Model
Figure 49. Metformin Hydrochloride Sustained-release Drug Sales Model
Figure 50. Metformin Hydrochloride Sustained-release Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
